1 result(s) displayed (1 - 1 of 1):
Merck & Co. (NYSE:MRK) and Schering-Plough Corp. (NYSE:SGP) have agreed to settle civil claims related to their jointly marketed cholesterol drugs. The companies were accused of delaying the release of unfavorable test results on Vytorin and Zetia, blockbuster drugs marketed through a Merck-Schering-Plough joint venture. On Wednesday, the partners settled...
Posted on July 15, 2009 1:52 PM
Movable Type search results powered by Fast Search